BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

Rhea-AI Summary

BioStem Technologies (OTC: BSEM) will release its fourth quarter and full year 2025 financial results on March 24, 2026 and host a conference call and webcast at 4:30 PM ET.

Presenters include CEO Jason Matuszewski and CFO Brandon Poe. Registration and webcast access are available via the company's provided links and phone numbers.

News Market Reaction – BSEM

+1.54%

1 alert

+1.54% News Effect

On the day this news was published, BSEM gained 1.54%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference call and webcast to be held at 4:30 PM ET

POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative medicine, today announces it will release its fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026, and will host a conference call and webcast at 4:30 PM ET.

The webcast will feature an overview of the quarter from Jason Matuszewski, CEO, and Brandon Poe, CFO. To register for the event, please click HERE.

Conference Call & Webcast Information:

• Conference ID: 9695874
• North America Toll-Free: (800) 715-9871
• International Toll: +1 (646) 307-1963
• Webcast Link: https://events.q4inc.com/attendee/218077167

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain^® processing method. BioRetain^® has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). Our portfolio of quality brands includes VENDAJE^®, VENDAJE AC^®, American Amnion™, American Amnion AC™, and Neox® and Clarix® product lines. For more information visit biostemtechnologies.com and follow us on X and LinkedIn.

Join BioStem’s Distribution List & Social Media:
To follow the latest developments at BioStem, sign up for the Company’s email distribution list HERE, and follow us on X and LinkedIn.

Contact BioStem:
Website: www.biostemtechnologies.com
E-Mail: info@biostemtech.com
X: @BSEM_Tech
Facebook: BioStemTechnologies
Phone: 954-380-8342

Investor Relations:
Philip Trip Taylor, Gilmartin
E-Mail: ir@biostemtech.com

FAQ

When will BioStem Technologies (BSEM) release Q4 and full year 2025 results and hold the conference call?

BioStem will release results and host a call on March 24, 2026 at 4:30 PM ET. According to the company, the call will present fourth quarter and full year 2025 financial results and include remarks from the CEO and CFO via webcast.

Who will present on the BioStem (BSEM) March 24, 2026 webcast and what will they cover?

The webcast will feature CEO Jason Matuszewski and CFO Brandon Poe presenting an overview of the quarter. According to the company, they will discuss fourth quarter and full year 2025 financial results and provide context for investors via live Q&A.

How can investors join the BioStem (BSEM) March 24, 2026 conference call and webcast?

Investors can join via the provided webcast link or dial the conference call numbers with Conference ID 9695874. According to the company, North America toll-free and international numbers plus a webcast registration link are available for attendees.

What is the conference ID and phone access for BioStem Technologies (BSEM) March 24, 2026 call?

The conference ID is 9695874, with North America toll-free (800) 715-9871 and international +1 (646) 307-1963. According to the company, these numbers provide live audio access alongside the webcast for investors.

Where can I find more information and sign up for BioStem Technologies (BSEM) investor updates?

More information and the distribution list sign-up are available on the company website and social channels. According to the company, investors can register via the webcast link and follow BioStem on X and LinkedIn for updates.